Search results
Found 12084 matches for
OxStem, an Oxford spin-out founded by Prof. Steve Davies, Prof. Angela Russell and DPAG's Prof. Dame Kay Davies, has raised a record £16.9M to develop small molecule drug candidates to treat age-related conditions including cancer, neurodegenerative diseases and heart failure.
OPDC Rapid eye-movement sleep Behaviour Disorder (RBD) Registration
Please complete the contact form below if you would like to find out more about RBD research at the OPDC.